Foetal therapies and their influence on preterm birth.
Fetoscopy
Foetal medicine
Foetal surgery
Foetal therapy
Premature rupture of membranes
Preterm birth
Journal
Seminars in immunopathology
ISSN: 1863-2300
Titre abrégé: Semin Immunopathol
Pays: Germany
ID NLM: 101308769
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
29
06
2020
accepted:
26
07
2020
pubmed:
14
8
2020
medline:
25
5
2021
entrez:
14
8
2020
Statut:
ppublish
Résumé
Foetal therapy aims to improve perinatal survival or to prevent severe long-term handicap. Foetal medicine opens a new territory by treating the foetus as a patient. The mother has nothing to gain in terms of health benefits, yet she is inherently also undergoing treatment. In utero foetal interventions can be divided into ultrasound-guided minimally invasive procedures, fetoscopic procedures and open hysterotomy procedures, which carry an inherent risk of ruptured membranes and preterm birth. In this review, we summarise the conditions that may benefit from foetal therapy and review the current therapies on offer, each with their associated risk of ruptured membrane and preterm birth. We also look into some risk limiting and preventative strategies to mitigate these complications.
Identifiants
pubmed: 32785752
doi: 10.1007/s00281-020-00811-2
pii: 10.1007/s00281-020-00811-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
501-514Subventions
Organisme : Fonds Wetenschappelijk Onderzoek
ID : 1804718N